NDA for Investors UK: Should You Ask an Investor to Sign?

The VC problem: why institutional investors rarely sign NDAs

If you approach a partner at a UK venture capital firm and ask them to sign an NDA before pitching your idea, the most likely outcome is a polite refusal. This is not because VCs are cavalier about confidentiality — it is a structural problem. A VC fund reviewing 200 deals a year across a sector will encounter similar ideas repeatedly. Signing an NDA for each pitch creates potential conflicts with every other deal in the same space, and managing those obligations is practically and legally unworkable.

The practical implication: at an initial pitch meeting, you are not protected by an NDA. What you are protected by is the reputational cost to the investor of misusing your information in a tight industry where word travels fast. This is a genuine, market-discipline-enforced form of protection — but it is not a contractual one.

The exception is later-stage due diligence. Once a term sheet is being discussed, or once a VC is asking for detailed customer lists, proprietary technical documentation, or financial data beyond the headline numbers, an NDA or a confidentiality schedule in the term sheet is entirely normal and investors will accept it.

When investors will sign: angels, family offices and strategic partners

Not all investors behave like institutional VCs. The following categories are substantially more likely to sign an investor NDA:

• Angel investors — individual high-net-worth investors, particularly those who are less active or operating outside the mainstream VC ecosystem, typically have fewer conflicts and are more willing to sign an NDA at an earlier stage.
• Family offices — private investment vehicles for wealthy families, often investing in a single sector, have no portfolio-conflict problem with signing an NDA for a specific deal.
• Strategic corporate investors — when a larger company is considering investing in a startup as part of a partnership or acquisition exploration, an NDA is standard at the outset. Both parties are disclosing sensitive information.
• Co-founders and early team members — before any equity arrangement is formalised, an NDA is appropriate with anyone you are sharing business-critical detail with. Once employment begins, this is covered by the employee NDA.
• Advisers and consultants — anyone giving paid or equity-compensated advice who needs access to proprietary financial or technical information should sign an NDA, even if they are not direct investors.

What an investor NDA must contain

A generic NDA template is not sufficient for an investor relationship. An investor-specific NDA should include:

• Non-circumvention clause — prevents the investor using your confidential information or the contacts you introduced to replicate your opportunity without you. NDASafe's Investor NDA defaults to a 12-month non-circumvention period (max 24 months).
• No-poach clause — the investor may not solicit or hire your key employees or founders during the NDA period and for a specified period thereafter. NDASafe's template uses a 12-month no-poach.
• Purpose limitation — the confidential information may only be used to evaluate the potential investment; it cannot be used for any other commercial purpose.
• Trade secret survival — general confidentiality obligations may expire after two to five years, but trade secrets should be protected indefinitely because their commercial value does not expire on a fixed date.
• Return or destruction on request — the investor must return or certifiably destroy all copies of confidential materials, including notes and analysis, if the deal does not proceed.
• UK GDPR data-handling clause — if disclosed materials include personal data (customer or employee information), a data-handling clause is required to set out how that data is processed and protected.

What an investor NDA cannot do

• It cannot protect your idea. A business concept, a market insight, or a problem statement is not protectable by an NDA. The NDA protects the specific, documented information you share — your financial model, customer data, source code, proprietary processes.
• It cannot prevent an investor from funding a competitor. An NDA does not create a non-compete. If an investor can show they funded a competing business independently, without using your confidential information, the NDA does not stop them.
• It cannot stop a VC from discussing general trends in your sector with other founders. The NDA covers specific confidential information, not general market knowledge the investor already has or develops independently.
• It cannot replace registered IP. For novel technology, a patent or design right registration creates a property right enforceable without having to prove what was disclosed to whom.

How to present an NDA without damaging the relationship

The manner in which you introduce an NDA matters as much as its content. A brief, professional note — 'I attach a short NDA as the materials I am sharing include proprietary financial projections and customer data' — frames the request as standard business practice rather than an accusation of bad intent.

Keep the agreement short, clearly written, and proportionate. An investor who receives a 15-page agreement drafted for a multinational M&A transaction will reject it on principle. An investor who receives a well-structured two-page agreement that takes five minutes to read will almost always sign it.

If the investor declines to sign: do not share the sensitive specifics. Share the concept, the market opportunity, and high-level projections. Reserve the detailed model, customer data, and proprietary IP for a stage when confidentiality obligations can be agreed.

Duration and governing law

NDASafe's Investor NDA defaults to a five-year confidentiality term for general business information, with trade secrets protected indefinitely. The non-circumvention period defaults to 12 months. These are negotiating baselines — sophisticated investors may push for shorter general terms (two to three years), and you may push for longer non-circumvention.

The agreement is governed by English and Welsh law as standard, with Scotland and Northern Ireland as alternatives. For deals involving overseas investors, English law is widely recognised and accepted. Where the investor entity is based in a jurisdiction without strong enforcement treaty arrangements with England and Wales, registered intellectual property (patents, design rights) provides an additional layer of protection that does not depend on enforcing a contractual right abroad.